tiprankstipranks
Trending News
More News >
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
US Market

Zealand Pharma (ZLDPF) Ratios

Compare
194 Followers

Zealand Pharma Ratios

ZLDPF's free cash flow for Q4 2025 was kr0.88. For the 2025 fiscal year, ZLDPF's free cash flow was decreased by kr and operating cash flow was kr-7.41. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
23.57 23.57 21.14 6.25 6.73
Quick Ratio
23.57 23.57 21.11 6.23 6.73
Cash Ratio
6.88 6.88 1.19 1.58 5.47
Solvency Ratio
3.97 3.97 -1.18 -1.75 -1.29
Operating Cash Flow Ratio
9.82 9.82 -2.31 -1.50 -4.82
Short-Term Operating Cash Flow Coverage
288.64 288.64 -58.05 0.00 0.00
Net Current Asset Value
kr 14.04Bkr 14.04Bkr 7.64Bkr 1.39Bkr 592.46M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.04 0.06 0.29
Debt-to-Equity Ratio
0.03 0.03 0.05 0.07 0.54
Debt-to-Capital Ratio
0.03 0.03 0.04 0.07 0.35
Long-Term Debt-to-Capital Ratio
0.03 0.03 0.03 0.00 0.28
Financial Leverage Ratio
1.11 1.11 1.10 1.24 1.89
Debt Service Coverage Ratio
106.80 110.01 -17.78 -22.31 -15.56
Interest Coverage Ratio
186.58 189.81 -31.11 -19.75 -14.46
Debt to Market Cap
0.02 0.01 <0.01 0.00 0.03
Interest Debt Per Share
7.41 7.43 6.51 2.62 10.82
Net Debt to EBITDA
-0.59 -0.57 0.09 0.51 0.71
Profitability Margins
Gross Profit Margin
99.83%99.69%87.44%94.41%70.47%
EBIT Margin
75.08%77.66%-1662.99%-198.34%-880.49%
EBITDA Margin
75.38%77.95%-1621.76%-190.08%-850.96%
Operating Profit Margin
75.52%77.66%-2029.33%-166.94%-785.30%
Pretax Profit Margin
75.98%75.98%-1728.23%-206.79%-934.78%
Net Profit Margin
70.05%70.05%-1720.87%-205.30%-928.60%
Continuous Operations Profit Margin
70.05%70.05%-1720.87%-205.30%-928.60%
Net Income Per EBT
92.20%92.20%99.57%99.28%99.34%
EBT Per EBIT
100.60%97.84%85.16%123.88%119.04%
Return on Assets (ROA)
39.21%39.21%-11.35%-35.54%-62.71%
Return on Equity (ROE)
47.89%43.52%-12.52%-44.18%-118.35%
Return on Capital Employed (ROCE)
44.06%45.30%-13.98%-33.75%-60.74%
Return on Invested Capital (ROIC)
40.56%41.71%-13.87%-33.18%-59.69%
Return on Tangible Assets
39.32%39.32%-11.36%-35.76%-62.71%
Earnings Yield
31.82%19.63%-2.27%-3.33%-10.38%
Efficiency Ratios
Receivables Turnover
28.82 28.82 0.45 2.80 0.76
Payables Turnover
0.05 0.11 0.04 0.21 0.17
Inventory Turnover
0.00 0.00 0.74 2.42 23.88
Fixed Asset Turnover
60.85 60.85 0.50 2.29 0.63
Asset Turnover
0.56 0.56 <0.01 0.17 0.07
Working Capital Turnover Ratio
0.61 0.80 0.01 0.26 0.08
Cash Conversion Cycle
-7.89K -3.31K -7.10K -1.46K -1.65K
Days of Sales Outstanding
12.66 12.66 809.14 130.29 481.66
Days of Inventory Outstanding
0.00 0.00 495.91 151.05 15.28
Days of Payables Outstanding
7.90K 3.32K 8.40K 1.74K 2.15K
Operating Cycle
12.66 12.66 1.31K 281.34 496.94
Cash Flow Ratios
Operating Cash Flow Per Share
92.51 92.65 -14.01 -7.52 -20.39
Free Cash Flow Per Share
92.00 92.18 -14.21 -7.94 -20.65
CapEx Per Share
0.51 0.47 0.20 0.42 0.25
Free Cash Flow to Operating Cash Flow
0.99 0.99 1.01 1.06 1.01
Dividend Paid and CapEx Coverage Ratio
181.55 195.77 -70.80 -17.92 -80.46
Capital Expenditure Coverage Ratio
181.55 195.77 -70.80 -17.92 -80.46
Operating Cash Flow Coverage Ratio
13.44 13.44 -2.38 -3.57 -2.12
Operating Cash Flow to Sales Ratio
0.71 0.71 -14.85 -1.24 -9.06
Free Cash Flow Yield
32.02%19.76%-1.99%-2.13%-10.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.06 5.09 -44.06 -30.01 -9.64
Price-to-Sales (P/S) Ratio
2.14 3.57 758.22 61.61 89.48
Price-to-Book (P/B) Ratio
1.33 2.22 5.52 13.26 11.40
Price-to-Free Cash Flow (P/FCF) Ratio
3.04 5.06 -50.36 -46.99 -9.75
Price-to-Operating Cash Flow Ratio
3.02 5.03 -51.07 -49.61 -9.88
Price-to-Earnings Growth (PEG) Ratio
-2.26 >-0.01 -1.44 0.74 0.80
Price-to-Fair Value
1.33 2.22 5.52 13.26 11.40
Enterprise Value Multiple
2.25 4.01 -46.67 -31.91 -9.81
Enterprise Value
16.19B 28.79B 47.45B 20.79B 8.68B
EV to EBITDA
2.33 4.01 -46.67 -31.91 -9.81
EV to Sales
1.76 3.12 756.81 60.65 83.46
EV to Free Cash Flow
2.49 4.43 -50.26 -46.26 -9.10
EV to Operating Cash Flow
2.48 4.41 -50.97 -48.84 -9.21
Tangible Book Value Per Share
209.41 209.72 129.51 27.93 17.66
Shareholders’ Equity Per Share
210.04 210.36 129.70 28.15 17.66
Tax and Other Ratios
Effective Tax Rate
0.08 0.08 <0.01 <0.01 <0.01
Revenue Per Share
130.51 130.71 0.94 6.06 2.25
Net Income Per Share
91.42 91.56 -16.24 -12.44 -20.90
Tax Burden
0.92 0.92 1.00 0.99 0.99
Interest Burden
1.01 0.98 1.04 1.04 1.06
Research & Development to Revenue
0.17 0.17 14.67 2.00 5.91
SG&A to Revenue
0.03 0.00 2.56 0.22 2.64
Stock-Based Compensation to Revenue
<0.01 0.00 1.39 0.18 0.50
Income Quality
1.01 1.01 0.86 0.60 0.78
Currency in DKK